Changes

Line 39: Line 39:  
*Predominantly affects adults in the fifth and sixth decades of life
 
*Predominantly affects adults in the fifth and sixth decades of life
 
*Male preponderance
 
*Male preponderance
*Unknown etiology in most cases  
+
*Unknown etiology in most cases
 
*Possible causes include chronic antigenic stimulation by intradermally applied antigens (e.g. tattoo pigments, vaccines, tick-borne bacteria, etc.)
 
*Possible causes include chronic antigenic stimulation by intradermally applied antigens (e.g. tattoo pigments, vaccines, tick-borne bacteria, etc.)
 
*Association with ''Borrelia burgdorferi'' infection in endemic Europe but not associated in USA or Asia
 
*Association with ''Borrelia burgdorferi'' infection in endemic Europe but not associated in USA or Asia
Line 56: Line 56:  
==Morphologic Features==
 
==Morphologic Features==
   −
* Dense dermal infiltrate composed of:
+
*Dense dermal infiltrate composed of:
** Small lymphocytes
+
**Small lymphocytes
** Plasma cells
+
**Plasma cells
*** Located at periphery of lymphoid infiltrates or in subepidermal compartment
+
***Located at periphery of lymphoid infiltrates or in subepidermal compartment
*** Heavy chain immunophenotype show different morphologies:  
+
***Heavy chain immunophenotype show different morphologies:  
**** Non-class-switched forms  
+
****Non-class-switched forms  
***** Sheets of B-lymphocytes and few T-lymphocytes
+
*****Sheets of B-lymphocytes and few T-lymphocytes
***** Scattered plasma cells  
+
*****Scattered plasma cells
**** Class-switched forms  
+
****Class-switched forms  
***** Large number of reactive T-lymphocytes but can occasionally be obscured by the neoplastic B cells  
+
*****Large number of reactive T-lymphocytes but can occasionally be obscured by the neoplastic B cells
***** Peripherally clustered monotypic plasma cells  
+
*****Peripherally clustered monotypic plasma cells
** Follicles with reactive germinal centers (most cases)
+
**Follicles with reactive germinal centers (most cases)
** clusters of plasmacytoid dendritic cells at periphery of infiltrates  
+
**clusters of plasmacytoid dendritic cells at periphery of infiltrates
    
==Immunophenotype==
 
==Immunophenotype==
   −
* Neoplastic B cells have the following immunophenotype:
+
*Neoplastic B cells have the following immunophenotype:
    
{| class="wikitable sortable"
 
{| class="wikitable sortable"
Line 86: Line 86:  
|Negative||BCL6
 
|Negative||BCL6
 
|-
 
|-
|Negative  
+
|Negative
 
|Cyclin D1
 
|Cyclin D1
 
|}
 
|}
   −
* The reactive germinal centers B cells are BCL6 positive and BCL2 negative.  
+
*The reactive germinal centers B cells are BCL6 positive and BCL2 negative.
* CD123 positive plasmacytoid dendritic cells.  
+
*CD123 positive plasmacytoid dendritic cells.
* Plasma cells have monotypic expression of immunoglobulin light chains often. Heavy chain class-switched form IgG, IgA, or IgE and have no expression of CXCR3. If non-class-switched forms are present, IgM and CXCR3 are expressed.
+
*Plasma cells have monotypic expression of immunoglobulin light chains often. Heavy chain class-switched form IgG, IgA, or IgE and have no expression of CXCR3. If non-class-switched forms are present, IgM and CXCR3 are expressed.
** Approximately 90% of cases have IgG, IgA, or IgE positivity
+
**Approximately 90% of cases have IgG, IgA, or IgE positivity
** Approximately 10% of cases have IgM positivity  
+
**Approximately 10% of cases have IgM positivity
* IgG4 expressed by plasma cells in 13-35% of cases, though not related to IgG4-related disease.  
+
*IgG4 expressed by plasma cells in 13-35% of cases, though not related to IgG4-related disease.
    
==Chromosomal Rearrangements (Gene Fusions)==
 
==Chromosomal Rearrangements (Gene Fusions)==
Line 225: Line 225:  
|''FAS'' (CD95) gene mutation
 
|''FAS'' (CD95) gene mutation
 
|Apoptosis regulator
 
|Apoptosis regulator
|>60% of cases  
+
|>60% of cases
 
|
 
|
 
|
 
|
Line 298: Line 298:  
==Additional Information==
 
==Additional Information==
   −
Put your text here
+
* Favorable prognosis
 +
** 5-year disease-specific survival rate >98%
 +
* Recurrence is common
 +
* 4% of patients will have extracutaneous spread, particularly in patients with longstanding multifocal disease
    
==Links==
 
==Links==